UK Vet Price Transparency Rules Take Effect as Pet Care Inflation Draws Scrutiny in the US and Sweden

The first tranche of the Competition and Markets Authority’s veterinary reforms comes into force today 22nd September 2026, capping written prescription fees and compelling practices to publish prices and disclose ownership. Britain is not acting in isolation: US pet prices hit a record high in August on the back of veterinary costs, while Swedish consumer trust in the profession has fallen sharply after a 40% rise in treatment costs since 2020.

From the 22nd September 2026, larger UK veterinary groups must publish fuller price lists, make corporate ownership visible to clients, and itemise bills. Written prescription fees are capped at £21 for a first medicine and £12.50 for each additional item, with practices obliged to tell owners that a written prescription can be requested. For treatments expected to cost £500 or more, written estimates must be provided in advance, with emergencies exempt.

The CMA’s investigation found that fewer than 40% of practices displayed prices on their websites and that many owners were unaware their local surgery belonged to a chain. Further measures, including an independent veterinary ombudsman with binding powers and a licensing regime for veterinary businesses, remain under consideration in the government’s White Paper.

The pressure is not confined to Britain. In the United States, pet prices reached a record high in August, rising 3.2% year on year, with veterinary costs identified as the principal driver. Cumulative inflation is visibly reshaping consumer behaviour, pushing owners toward cheaper alternatives — a pattern already visible in Zoetis and Elanco earnings commentary on reduced clinic visits and heightened price sensitivity.

In Sweden, the disconnect is starker still. Satisfaction with individual veterinarians remains high, yet sector-level trust has deteriorated as treatment costs have climbed 40% since 2020. Industry leaders have promised clearer pricing while calling on government to examine VAT treatment and the role of the public sector in veterinary provision.

Three markets, three regulatory postures — but a single underlying problem: veterinary cost inflation is now outpacing what owners believe they can reasonably absorb, and trust is eroding faster than prices are rising.